APO Research
Talk to an analyst

APO RESEARCH · REPORT

Radiopharmaceutical Freeze-Dried Products

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Radiopharmaceutical Freeze-Dried Products Market Outlook and Growth Opportunities 2026

28 December 2025196 pages

Choose your research edition.

Industry ResearchRadiopharmaceutical Freeze-Dried Products Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Radiopharmaceutical Freeze-Dried Products Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Radiopharmaceutical Freeze-Dried Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Radiopharmaceutical Freeze-Dried Products Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Radiopharmaceutical Freeze-Dried Products Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Radiopharmaceutical Freeze-Dried Products market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Radiopharmaceutical Freeze-Dried Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Radiopharmaceutical Freeze-Dried Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Radiopharmaceutical Freeze-Dried Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Radiopharmaceutical Freeze-Dried Products market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Radiopharmaceutical Freeze-Dried Products market include Rosatom, NTP, NRG, IRE and ANSTO, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Radiopharmaceutical Freeze-Dried Products market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Radiopharmaceutical Freeze-Dried Products and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Radiopharmaceutical Freeze-Dried Products revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Radiopharmaceutical Freeze-Dried Products market.

Radiopharmaceutical Freeze-Dried Products Segment by Company

Rosatom

NTP

NRG

IRE

ANSTO

Radiopharmaceutical Freeze-Dried Products Segment by Type

Bone Imaging Kits

Renal (Kidney) Imaging Kits

Cardiac (Heart) Imaging Kits

Others

Radiopharmaceutical Freeze-Dried Products Segment by Application

Hospital

Clinic

Radiopharmaceutical Freeze-Dried Products Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Radiopharmaceutical Freeze-Dried Products status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Radiopharmaceutical Freeze-Dried Products key companies, revenue, market share, and recent developments.

3. To split the Radiopharmaceutical Freeze-Dried Products breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Radiopharmaceutical Freeze-Dried Products market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Radiopharmaceutical Freeze-Dried Products significant trends, drivers, influence factors in global and regions.

6. To analyze Radiopharmaceutical Freeze-Dried Products competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radiopharmaceutical Freeze-Dried Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Radiopharmaceutical Freeze-Dried Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radiopharmaceutical Freeze-Dried Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Radiopharmaceutical Freeze-Dried Products industry.

Chapter 3: Detailed analysis of Radiopharmaceutical Freeze-Dried Products company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Radiopharmaceutical Freeze-Dried Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Radiopharmaceutical Freeze-Dried Products in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Radiopharmaceutical Freeze-Dried Products Industry Trends Table 2. Radiopharmaceutical Freeze-Dried Products Industry Drivers Table 3. Radiopharmaceutical Freeze-Dried Products Industry Opportunities and Challenges Table 4. Radiopharmaceutical Freeze-Dried Products Industry Restraints Table 5. Global Radiopharmaceutical Freeze-Dried Products Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Radiopharmaceutical Freeze-Dried Products Revenue Share by Company (2021-2026) Table 7. Global Radiopharmaceutical Freeze-Dried Products Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Radiopharmaceutical Freeze-Dried Products Key Company Manufacturing Base & Headquarters Table 9. Global Radiopharmaceutical Freeze-Dried Products Company, Product Type & Application Table 10. Global Radiopharmaceutical Freeze-Dried Products Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Radiopharmaceutical Freeze-Dried Products by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Bone Imaging Kits Table 15. Significant Companies of Renal (Kidney) Imaging Kits Table 16. Significant Companies of Cardiac (Heart) Imaging Kits Table 17. Significant Companies of Others Table 18. Global Radiopharmaceutical Freeze-Dried Products Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Radiopharmaceutical Freeze-Dried Products Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Radiopharmaceutical Freeze-Dried Products Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type (2021-2026) Table 22. Global Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Hospital Table 24. Significant Companies of Clinic Table 25. Global Radiopharmaceutical Freeze-Dried Products Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Radiopharmaceutical Freeze-Dried Products Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Radiopharmaceutical Freeze-Dried Products Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application (2021-2026) Table 29. Global Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application (2027-2032) Table 30. Global Radiopharmaceutical Freeze-Dried Products Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Radiopharmaceutical Freeze-Dried Products Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Radiopharmaceutical Freeze-Dried Products Sales Value Share by Region (2021-2026) Table 33. Global Radiopharmaceutical Freeze-Dried Products Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Radiopharmaceutical Freeze-Dried Products Sales Value Share by Region (2027-2032) Table 35. Global Radiopharmaceutical Freeze-Dried Products Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Radiopharmaceutical Freeze-Dried Products Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Radiopharmaceutical Freeze-Dried Products Sales Value Market Share by Country (2021-2026) Table 38. Global Radiopharmaceutical Freeze-Dried Products Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Radiopharmaceutical Freeze-Dried Products Sales Value Market Share by Country (2027-2032) Table 40. Rosatom Company Information Table 41. Rosatom Business Overview Table 42. Rosatom Radiopharmaceutical Freeze-Dried Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Rosatom Radiopharmaceutical Freeze-Dried Products Product Portfolio Table 44. Rosatom Recent Development Table 45. NTP Company Information Table 46. NTP Business Overview Table 47. NTP Radiopharmaceutical Freeze-Dried Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. NTP Radiopharmaceutical Freeze-Dried Products Product Portfolio Table 49. NTP Recent Development Table 50. NRG Company Information Table 51. NRG Business Overview Table 52. NRG Radiopharmaceutical Freeze-Dried Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. NRG Radiopharmaceutical Freeze-Dried Products Product Portfolio Table 54. NRG Recent Development Table 55. IRE Company Information Table 56. IRE Business Overview Table 57. IRE Radiopharmaceutical Freeze-Dried Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. IRE Radiopharmaceutical Freeze-Dried Products Product Portfolio Table 59. IRE Recent Development Table 60. ANSTO Company Information Table 61. ANSTO Business Overview Table 62. ANSTO Radiopharmaceutical Freeze-Dried Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. ANSTO Radiopharmaceutical Freeze-Dried Products Product Portfolio Table 64. ANSTO Recent Development Table 65. Research Programs/Design for This Report Table 66. Authors List of This Report Table 67. Secondary Sources Table 68. Primary Sources List of Figures Figure 1. Radiopharmaceutical Freeze-Dried Products Product Image Figure 2. Global Radiopharmaceutical Freeze-Dried Products Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Radiopharmaceutical Freeze-Dried Products Market Size (2021-2032) & (US$ Million) Figure 4. Global Radiopharmaceutical Freeze-Dried Products Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Bone Imaging Kits Image Figure 8. Renal (Kidney) Imaging Kits Image Figure 9. Cardiac (Heart) Imaging Kits Image Figure 10. Others Image Figure 11. Global Radiopharmaceutical Freeze-Dried Products Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Radiopharmaceutical Freeze-Dried Products Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type (2021-2032) Figure 14. Hospital Image Figure 15. Clinic Image Figure 16. Global Radiopharmaceutical Freeze-Dried Products Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Radiopharmaceutical Freeze-Dried Products Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application (2021-2032) Figure 19. Global Radiopharmaceutical Freeze-Dried Products Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Radiopharmaceutical Freeze-Dried Products Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Radiopharmaceutical Freeze-Dried Products Sales Value (2021-2032) & (US$ Million) Figure 22. North America Radiopharmaceutical Freeze-Dried Products Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Radiopharmaceutical Freeze-Dried Products Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Radiopharmaceutical Freeze-Dried Products Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Radiopharmaceutical Freeze-Dried Products Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Radiopharmaceutical Freeze-Dried Products Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Radiopharmaceutical Freeze-Dried Products Sales Value (2021-2032) & (US$ Million) Figure 28. South America Radiopharmaceutical Freeze-Dried Products Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Radiopharmaceutical Freeze-Dried Products Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Radiopharmaceutical Freeze-Dried Products Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Bone Imaging Kits
  • Renal (Kidney) Imaging Kits
  • Cardiac (Heart) Imaging Kits
  • Others
Applications
  • Hospital
  • Clinic
Companies covered
  • Rosatom
  • NTP
  • NRG
  • IRE
  • ANSTO

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Radiopharmaceutical Freeze-Dried Products Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Radiopharmaceutical Freeze-Dried Products Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Radiopharmaceutical Freeze-Dried Products Market Dynamics
  1. 2.1 Radiopharmaceutical Freeze-Dried Products Industry Trends
  2. 2.2 Radiopharmaceutical Freeze-Dried Products Industry Drivers
  3. 2.3 Radiopharmaceutical Freeze-Dried Products Industry Opportunities and Challenges
  4. 2.4 Radiopharmaceutical Freeze-Dried Products Industry Restraints
3 Radiopharmaceutical Freeze-Dried Products Market by Company
  1. 3.1 Global Radiopharmaceutical Freeze-Dried Products Company Revenue Ranking in 2025
  2. 3.2 Global Radiopharmaceutical Freeze-Dried Products Revenue by Company (2021-2026)
  3. 3.3 Global Radiopharmaceutical Freeze-Dried Products Company Ranking (2024-2026)
  4. 3.4 Global Radiopharmaceutical Freeze-Dried Products Company Manufacturing Base and Headquarters
  5. 3.5 Global Radiopharmaceutical Freeze-Dried Products Company Product Type and Application
  6. 3.6 Global Radiopharmaceutical Freeze-Dried Products Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Radiopharmaceutical Freeze-Dried Products Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Radiopharmaceutical Freeze-Dried Products Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Radiopharmaceutical Freeze-Dried Products Market by Type
  1. 4.1 Radiopharmaceutical Freeze-Dried Products Type Introduction
  2. 4.1.1 Bone Imaging Kits
  3. 4.1.2 Renal (Kidney) Imaging Kits
  4. 4.1.3 Cardiac (Heart) Imaging Kits
  5. 4.1.4 Others
  6. 4.2 Global Radiopharmaceutical Freeze-Dried Products Sales Value by Type
  7. 4.2.1 Global Radiopharmaceutical Freeze-Dried Products Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Radiopharmaceutical Freeze-Dried Products Sales Value by Type (2021-2032)
  9. 4.2.3 Global Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type (2021-2032)
5 Radiopharmaceutical Freeze-Dried Products Market by Application
  1. 5.1 Radiopharmaceutical Freeze-Dried Products Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Radiopharmaceutical Freeze-Dried Products Sales Value by Application
  5. 5.2.1 Global Radiopharmaceutical Freeze-Dried Products Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Radiopharmaceutical Freeze-Dried Products Sales Value by Application (2021-2032)
  7. 5.2.3 Global Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application (2021-2032)
6 Radiopharmaceutical Freeze-Dried Products Regional Value Analysis
  1. 6.1 Global Radiopharmaceutical Freeze-Dried Products Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Radiopharmaceutical Freeze-Dried Products Sales Value by Region (2021-2032)
  3. 6.2.1 Global Radiopharmaceutical Freeze-Dried Products Sales Value by Region: 2021-2026
  4. 6.2.2 Global Radiopharmaceutical Freeze-Dried Products Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Radiopharmaceutical Freeze-Dried Products Sales Value (2021-2032)
  7. 6.3.2 North America Radiopharmaceutical Freeze-Dried Products Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Radiopharmaceutical Freeze-Dried Products Sales Value (2021-2032)
  10. 6.4.2 Europe Radiopharmaceutical Freeze-Dried Products Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Radiopharmaceutical Freeze-Dried Products Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Radiopharmaceutical Freeze-Dried Products Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Radiopharmaceutical Freeze-Dried Products Sales Value (2021-2032)
  16. 6.6.2 South America Radiopharmaceutical Freeze-Dried Products Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Radiopharmaceutical Freeze-Dried Products Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Radiopharmaceutical Freeze-Dried Products Sales Value Share by Country, 2025 VS 2032
7 Radiopharmaceutical Freeze-Dried Products Country-level Value Analysis
  1. 7.1 Global Radiopharmaceutical Freeze-Dried Products Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Radiopharmaceutical Freeze-Dried Products Sales Value by Country (2021-2032)
  3. 7.2.1 Global Radiopharmaceutical Freeze-Dried Products Sales Value by Country (2021-2026)
  4. 7.2.2 Global Radiopharmaceutical Freeze-Dried Products Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Radiopharmaceutical Freeze-Dried Products Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Radiopharmaceutical Freeze-Dried Products Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Radiopharmaceutical Freeze-Dried Products Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Rosatom
  2. 8.1.1 Rosatom Company Information
  3. 8.1.2 Rosatom Business Overview
  4. 8.1.3 Rosatom Radiopharmaceutical Freeze-Dried Products Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Rosatom Radiopharmaceutical Freeze-Dried Products Product Portfolio
  6. 8.1.5 Rosatom Recent Developments
  7. 8.2 NTP
  8. 8.2.1 NTP Company Information
  9. 8.2.2 NTP Business Overview
  10. 8.2.3 NTP Radiopharmaceutical Freeze-Dried Products Revenue and Gross Margin (2021-2026)
  11. 8.2.4 NTP Radiopharmaceutical Freeze-Dried Products Product Portfolio
  12. 8.2.5 NTP Recent Developments
  13. 8.3 NRG
  14. 8.3.1 NRG Company Information
  15. 8.3.2 NRG Business Overview
  16. 8.3.3 NRG Radiopharmaceutical Freeze-Dried Products Revenue and Gross Margin (2021-2026)
  17. 8.3.4 NRG Radiopharmaceutical Freeze-Dried Products Product Portfolio
  18. 8.3.5 NRG Recent Developments
  19. 8.4 IRE
  20. 8.4.1 IRE Company Information
  21. 8.4.2 IRE Business Overview
  22. 8.4.3 IRE Radiopharmaceutical Freeze-Dried Products Revenue and Gross Margin (2021-2026)
  23. 8.4.4 IRE Radiopharmaceutical Freeze-Dried Products Product Portfolio
  24. 8.4.5 IRE Recent Developments
  25. 8.5 ANSTO
  26. 8.5.1 ANSTO Company Information
  27. 8.5.2 ANSTO Business Overview
  28. 8.5.3 ANSTO Radiopharmaceutical Freeze-Dried Products Revenue and Gross Margin (2021-2026)
  29. 8.5.4 ANSTO Radiopharmaceutical Freeze-Dried Products Product Portfolio
  30. 8.5.5 ANSTO Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst